Translate
Natera Inc
About
Natera Inc (NASDAQ:NTRA) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Prospera™ Evidence in Heart and Lung Transplantation Featured Across 17 Presentations at ISHLT
Apr 13 2026
Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics’ MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma
Apr 9 2026
Judge Awards 30% Ongoing Royalty to Natera for its MRD-Related Patents
Apr 7 2026
20 Abstracts at AACR Highlight Scale, Innovation and Clinical Impact of Natera’s Oncology Platform
Mar 31 2026
SignateraTM MRD Identifies Breast Cancer Patients Who Can Forgo Surgery
Recent Videos
Cancer testing. Natera. Signatura. #colorectalcancer #coloncancer #cancersurvivor #cancerawareness
Apr 22, 2026
Natera Stock Technical Analysis 🚀 | Massive Uptrend Potential (Is It a Buy?)
Apr 19, 2026
Culto De Damas & Caballeros - Predica: Carlos Natera
Apr 18, 2026
Marci's story | Lobular Breast Cancer Survivor
Apr 16, 2026
Financials
Revenue
$2.31 B
Market Cap
$29.48 B
EPS
-1.52